Akt and PTEN: New diagnostic markers of non-small cell lung cancer?

被引:19
|
作者
David, O [1 ]
机构
[1] Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70112 USA
关键词
Akt; PTEN; cell survival; immunohistochemistry; lung cancer;
D O I
10.1111/j.1582-4934.2001.tb00178.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We are particularly interested in testing the principles of cell proliferation and apoptosis in the microenvironment of human lung cancers with respect to the cell survival protein Akt (1) and PTEN (2). Akt is a cytosolic protein which promotes cell survival by phosphorylative inactivation of targets in apoptotic pathways. Akt has been found to play a role in the survival of experimental cancer cell lines in breast, prostate, ovary, lung and brain tissue. PTEN is a tumor suppressor gene whose protein product is expressed in inverse proportion to phosphorylated Akt in endometrial and breast cancer cell lines. No studies of the diagnostic significance of Akt and PTEN in human lung cancers have been reported.
引用
收藏
页码:430 / 433
页数:4
相关论文
共 50 条
  • [21] New Targets in Non-Small Cell Lung Cancer
    Park, Soo J.
    More, Soham
    Murtuza, Ayesha
    Woodward, Brian D.
    Husain, Hatim
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 113 - +
  • [22] New Targets in Non-Small Cell Lung Cancer
    Gadgeel, Shirish M.
    CURRENT ONCOLOGY REPORTS, 2013, 15 (04) : 411 - 423
  • [23] Plasma versican and plasma exosomal versican as potential diagnostic markers for non-small cell lung cancer
    Wenjing Chang
    Jichao Zhu
    Dianyu Yang
    Anquan Shang
    Zujun Sun
    Wenqiang Quan
    Dong Li
    Respiratory Research, 24
  • [24] Plasma versican and plasma exosomal versican as potential diagnostic markers for non-small cell lung cancer
    Chang, Wenjing
    Zhu, Jichao
    Yang, Dianyu
    Shang, Anquan
    Sun, Zujun
    Quan, Wenqiang
    Li, Dong
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [25] Correlation of cancer stem cell markers and immune cell markers in resected non-small cell lung cancer
    Huang, Zhaoqin
    Yu, Haining
    Zhang, Jianbo
    Jing, Haiyan
    Zhu, Wanqi
    Li, Xiaolin
    Kong, Lingling
    Xing, Ligang
    Yu, Jinming
    Meng, Xiangjiao
    JOURNAL OF CANCER, 2017, 8 (16): : 3190 - 3197
  • [26] Predictive markers in the adjuvant therapy of non-small cell lung cancer
    Filipits, Martin
    Pirker, Robert
    LUNG CANCER, 2011, 74 (03) : 355 - 363
  • [27] Influence of genetic markers on survival in non-small cell lung cancer
    Rosell, R
    Taron, M
    Camps, C
    López-Vivanco, G
    DRUGS OF TODAY, 2003, 39 (10): : 775 - 786
  • [28] Histological Markers Associated with Radiosensitivity in Non-Small Cell Lung Cancer
    Baena, J. D.
    Talbot, C. J.
    Le Quesne, J. P. C.
    JOURNAL OF PATHOLOGY, 2017, 243 : S26 - S26
  • [29] Prognostic markers for stage I non-small cell lung cancer
    Ohara, Gen
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    LUNG CANCER, 2008, 59 (01) : 137 - 137
  • [30] MicroRNA markers for erlotinib resistance in non-small cell lung cancer
    Nelson, Kristen
    Ranade, Aarati
    Kashey, Trevor
    Kingsley, Chris
    Weiss, Glen
    CANCER RESEARCH, 2009, 69